Table 1.
Characteristics of Study Sample.
| Characteristics | Number of Patients (%) |
|---|---|
| Sex | |
| Male | 36 (75.0%) |
| Female | 12 (25.0%) |
| Age (years) | |
| Median (range) | 47 (32-66) |
| Height (cm), mean ± SD | 163.23 ± 1.91 |
| Body weight (kg), mean ± SD | 62.23 ± 2.48 |
| Body mass index (kg/m2), mean ± SD | 23.34 ± 0.6 |
| TNM stage (AJCC 2007) | |
| II | 9 (18.8%) |
| III | 20 (41.7%) |
| IV A | 9 (18.8%) |
| IV B | 10 (20.8%) |
| Tumor stage | |
| T1 | 5 (10.4%) |
| T2 | 24 (50.0%) |
| T3 | 9 (18.8%) |
| T4 | 10 (20.8%) |
| Nodal stage | |
| N0 | 1 (2.1%) |
| N1 | 19 (39.6%) |
| N2 | 16 (33.3%) |
| N3 | 12 (25.0%) |
| Treatment | |
| CCRT | 3 (6.3%) |
| IC + CCRT | 45 (93.8%) |
| Radiation doses/fractions (Gy/F) | |
| 66/30 | 29 (60.4%) |
| 70.4/32 | 19 (39.6%) |
Abbreviations: TNM, tumor, node, and metastasis; AJCC, American Joint Committee on Cancer; CCRT, concurrent chemoradiotherapy; IC, induction chemotherapy.